창상 봉합 디바이스 시장 규모, 점유율 및 동향 분석 보고서 : 제품별, 창상별, 최종 용도별, 유통 채널별, 구입 형태별, 지역별 및 부문별 예측(2026-2033년)

Wound Closure Devices Market Summary

The global wound closure devices market size was estimated at USD 15.39 billion in 2025 and is projected to reach USD 25.19 billion by 2033, growing at a CAGR of 6.31% from 2026 to 2033. The market is primarily driven by the rising number of surgical procedures, increasing incidence of traumatic injuries, and the growing prevalence of chronic conditions such as diabetes.

Advancements in closure technologies that improve healing outcomes and reduce infection risks are further boosting adoption. In addition, expanding healthcare infrastructure and the shift toward minimally invasive procedures continue to support market growth. The growing prevalence of chronic wounds, particularly those associated with diabetes, vascular disorders, and aging populations, is significantly increasing the need for effective wound closure solutions. These wounds require prolonged care and advanced products to support healing and prevent complications.

As a result, demand for specialized closure devices and innovative treatment options continues to rise, driving market growth. According to an article published by MDPI in March 2025, diabetic foot remains one of the most severe and complex complications of diabetes, strongly associated with high rates of lower-limb amputation, as well as increased morbidity and mortality. Globally, approximately 18.6 million people are affected by diabetic foot ulcers each year, accounting for nearly 80% of diabetes-related lower limb amputations. It is further estimated that up to 25% of individuals with diabetes may develop diabetic foot, with 19%-34% experiencing foot ulcers during their lifetime.

Furthermore, the increasing incidence of sports-related injuries, such as cuts, lacerations, and soft-tissue damage, is significantly contributing to the growth of the market. Rising participation in fitness and recreational activities is driving demand for quick and effective wound management solutions, including sutures, staples, and adhesive closures. This trend further supports market expansion by promoting the adoption of advanced, minimally invasive wound closure technologies. The graph below illustrates the increase in exercise and equipment-related injuries from 2023 to 2024.

Global Wound Closure Devices Market Report Segmentation

This report forecasts revenue growth at the global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the global wound closure devices market report based on product, wound, end use, distribution channel, mode of purchase, and region.

• Product Outlook (Revenue, USD Million, 2021 - 2033)
• Sutures
  • Surgical Suture
  • Absorbable
  • Non-Absorbable
  • Barbed Suture (only Absorbable)
  • Uni-directional barbed suture
  • Bi-directional barbed suture
  • Gut Suture
  • Microsutures
• Adhesives
• Staples
  • Powered
  • Manual
• Strips
  • By Sterility
  • Sterile
  • Non-Sterile
  • By Product
  • Reinforced Strips
  • Flexible Strips
• Clips
• Sealants
  • Non-Synthetic
  • Collagen Based
  • Synthetic
  • Topical Cyanoacrylates
  • Others
• Others
• Wound Outlook (Revenue, USD Million, 2021 - 2033)
• Acute Wounds
  • Surgical/ Procedure
  • Obstetrics / Gynecology
  • Colorectal
  • Cardiovascular
  • Bariatric and Upper GI
  • Plastic and Reconstructive Surgery
  • Urology
  • Hepato-pancreato-biliary (HPB)
  • Dermatology
  • Others
  • Lacerations & Minor Cuts
  • Burns
• Chronic Wounds
  • Diabetic Foot Ulcers
  • Pressure Ulcers
  • Venous Leg Ulcers
• Other Chronic Wounds
• End Use Outlook (Revenue, USD Million, 2021 - 2033)
• Acute Care Hospital
• Ambulatory Surgery Center (ASC)
• Hospital Outpatient Wound Care Clinic
• Home Healthcare
• Skilled Nursing Facility (SNF)
• Physician Office
• Burn Center
• Inpatient Rehabilitation Facility (IRF)
• Long-term Acute Care Hospital (LTACH)
• Long-term Care (residential living setting)
• Distribution Channel Outlook (Revenue, USD Million, 2021 - 2033)
• Institutional Sales
• Retail Sales
• Mode of Purchase Outlook (Revenue, USD Million, 2021 - 2033)
• Prescribed
• Non-prescribed (OTC)
• Regional Outlook (Revenue, USD Million, 2021 - 2033)
• North America
  • U.S.
  • Canada
  • Mexico
• Europe
  • UK
  • Germany
  • Italy
  • France
  • Spain
  • Denmark
  • Sweden
  • Norway
• Asia Pacific
  • Japan
  • China
  • India
  • South Korea
  • Australia
  • Thailand
• Latin America
  • Brazil
  • Argentina
• MEA
  • South Africa
  • Saudi Arabia
  • UAE
  • Kuwait

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation and Scope
  • 1.1.1. Product
  • 1.1.2. Wound
  • 1.1.3. End Use
  • 1.1.4. Distribution Channel
  • 1.1.5. Mode of Purchase
  • 1.1.6. Regional scope
  • 1.1.7. Estimates and forecast timeline
• 1.2. Market Definitions
• 1.3. Research Methodology
• 1.4. Information Procurement
  • 1.4.1. Purchased Database
  • 1.4.2. GVR's Internal Database
• 1.5. Details of primary research
  • 1.5.1. Data for primary interviews in North America
  • 1.5.2. Data for primary interviews in Europe
  • 1.5.3. Data for primary interviews in Asia Pacific
  • 1.5.4. Data for primary interviews in Latin America
  • 1.5.5. Data for Primary interviews in MEA
• 1.6. Market Formulation & Validation
• 1.7. Model Details
  • 1.7.1. Commodity flow analysis (Model 1)
    • 1.7.1.1. Approach 1: Commodity flow approach
  • 1.7.2. Volume price analysis (Model 2)
    • 1.7.2.1. Approach 2: Volume price analysis
• 1.8. Research Scope and Assumptions
  • 1.8.1. List of Secondary Sources
  • 1.8.2. List of Primary Sources
• 1.9. Objectives

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Outlook
• 2.3. Competitive Insights

Chapter 3. Wound Closure Devices Market Variables, Trends, & Scope

• 3.1. Market Lineage Outlook
  • 3.1.1. Ancillary Market Outlook
• 3.2. Market Dynamics
  • 3.2.1. Market Driver Analysis
    • 3.2.1.1. Growing prevalence of chronic wounds
    • 3.2.1.2. Rising number of surgical procedures
    • 3.2.1.3. Advancements in wound closure products
  • 3.2.2. Market Restraint Analysis
    • 3.2.2.1. Recalls and adverse events associated with wound closure devices
  • 3.2.3. Market Opportunities Analysis
    • 3.2.3.1. Growing number of clinical trials
    • 3.2.3.2. Rising incidence of sports injuries and road accidents
    • 3.2.3.3. Increasing prevalence of chronic diseases
  • 3.2.4. Market Challenge Analysis
    • 3.2.4.1. Complications and risks associated with wound closures
• 3.3. Wound Closure Devices Market Analysis Tools
  • 3.3.1. Industry Analysis - Porter's
    • 3.3.1.1. Bargaining power of suppliers
    • 3.3.1.2. Bargaining power of buyers
    • 3.3.1.3. Threat of substitutes
    • 3.3.1.4. Threat of new entrants
    • 3.3.1.5. Competitive rivalry
  • 3.3.2. PESTEL Analysis
    • 3.3.2.1. Political & Legal Landscape
    • 3.3.2.2. Economic and Social Landscape
    • 3.3.2.3. Technological landscape

Chapter 4. Wound Closure Devices Market: Product Estimates & Trend Analysis

• 4.1. Segment Dashboard
• 4.2. Global Wound Closure Devices Market Movement Analysis
• 4.3. Global Wound Closure Devices Market Size & Trend Analysis, by Product, 2021 to 2033 (USD Million)
• 4.4. Sutures
  • 4.4.1. Sutures market estimates and forecast 2021 to 2033 (USD Million)
  • 4.4.2. Surgical Suture
    • 4.4.2.1. Surgical suture market estimates and forecast 2021 to 2033 (USD Million)
    • 4.4.2.2. Absorbable
      • 4.4.2.2.1. Absorbable market estimates and forecast 2021 to 2033 (USD Million)
    • 4.4.2.3. Non-absorbable
      • 4.4.2.3.1. Non-absorbable market estimates and forecast 2021 to 2033 (USD Million)
  • 4.4.3. Barbed suture
    • 4.4.3.1. Barbed suture market estimates and forecast 2021 to 2033 (USD Million)
    • 4.4.3.2. Uni-directional barbed suture
      • 4.4.3.2.1. Uni-directional barbed suture market estimates and forecast 2021 to 2033 (USD Million)
    • 4.4.3.3. Bi-directional barbed suture
      • 4.4.3.3.1. Bi-directional barbed suture market estimates and forecast 2021 to 2033 (USD Million)
  • 4.4.4. Gut Suture
    • 4.4.4.1. Gut Suture market estimates and forecast 2021 to 2033 (USD Million)
  • 4.4.5. Microsutures
    • 4.4.5.1. Microsutures market estimates and forecast 2021 to 2033 (USD Million)
• 4.5. Adhesives
  • 4.5.1. Adhesives market estimates and forecast 2021 to 2033 (USD Million)
• 4.6. Staples
  • 4.6.1. Staples market estimates and forecast 2021 to 2033 (USD Million)
  • 4.6.2. Powered
    • 4.6.2.1. Powered market estimates and forecast 2021 to 2033 (USD Million)
  • 4.6.3. Manual
    • 4.6.3.1. Manual market estimates and forecast 2021 to 2033 (USD Million)
• 4.7. Strips
  • 4.7.1. Strips market estimates and forecast 2021 to 2033 (USD Million)
  • 4.7.2. Sterile
    • 4.7.2.1. Sterile market estimates and forecast 2021 to 2033 (USD Million)
  • 4.7.3. Non-Sterile
    • 4.7.3.1. Non-sterile market estimates and forecast 2021 to 2033 (USD Million)
• 4.8. Clips
  • 4.8.1. Clips market estimates and forecast 2021 to 2033 (USD Million)
• 4.9. Sealants
  • 4.9.1. Sealants market estimates and forecast 2021 to 2033 (USD Million)
  • 4.9.2. Non-Synthetic
    • 4.9.2.1. Non-Synthetic market estimates and forecast 2021 to 2033 (USD Million)
  • 4.9.3. Collagen Based
    • 4.9.3.1. Collagen based market estimates and forecast 2021 to 2033 (USD Million)
  • 4.9.4. Synthetic
    • 4.9.4.1. Synthetic market estimates and forecast 2021 to 2033 (USD Million)
    • 4.9.4.2. Topical cyanoacrylates
      • 4.9.4.2.1. Topical cyanoacrylates market estimates and forecast 2021 to 2033 (USD Million)
    • 4.9.4.3. Others
      • 4.9.4.3.1. Others market estimates and forecast 2021 to 2033 (USD Million)
• 4.10. Others
  • 4.10.1. Others market estimates and forecast 2021 to 2033 (USD Million)

Chapter 5. Wound Closure Devices Market: Wound Estimates & Trend Analysis

• 5.1. Segment Dashboard
• 5.2. Global Wound Closure Devices Market Movement Analysis
• 5.3. Global Wound Closure Devices Market Size & Trend Analysis, by Wound, 2021 to 2033 (USD Million)
• 5.4. Acute Wounds
  • 5.4.1. Acute wounds market estimates and forecast 2021 to 2033 (USD Million)
  • 5.4.2. Surgical/ procedure
    • 5.4.2.1. Surgical/ procedure market estimates and forecast 2021 to 2033 (USD Million)
    • 5.4.2.2. Obstetrics / gynecology
      • 5.4.2.2.1. Obstetrics / gynecology market estimates and forecast 2021 to 2033 (USD Million)
    • 5.4.2.3. Colorectal
      • 5.4.2.3.1. Colorectal market estimates and forecast 2021 to 2033 (USD Million)
    • 5.4.2.4. Cardiovascular
      • 5.4.2.4.1. Cardiovascular market estimates and forecast 2021 to 2033 (USD Million)
    • 5.4.2.5. Bariatric and upper GI
      • 5.4.2.5.1. Bariatric and upper GI market estimates and forecast 2021 to 2033 (USD Million)
    • 5.4.2.6. Plastic and reconstructive surgery
      • 5.4.2.6.1. Plastic and reconstructive surgery market estimates and forecast 2021 to 2033 (USD Million)
    • 5.4.2.7. Urology
      • 5.4.2.7.1. Urology market estimates and forecast 2021 to 2033 (USD Million)
    • 5.4.2.8. Hepato-pancreato-biliary (HPB)
      • 5.4.2.8.1. Hepato-pancreato-biliary (HPB) market estimates and forecast 2021 to 2033 (USD Million)
    • 5.4.2.9. Dermatology
      • 5.4.2.9.1. Dermatology market estimates and forecast 2021 to 2033 (USD Million)
    • 5.4.2.10. Others
      • 5.4.2.10.1. Others market estimates and forecast 2021 to 2033 (USD Million)
  • 5.4.3. Lacerations & minor cuts
    • 5.4.3.1. Lacerations & minor cuts market estimates and forecast 2021 to 2033 (USD Million)
  • 5.4.4. Burns
    • 5.4.4.1. Burns market estimates and forecast 2021 to 2033 (USD Million)
• 5.5. Chronic Wounds
  • 5.5.1. Chronic wounds market estimates and forecast 2021 to 2033 (USD Million)
  • 5.5.2. Diabetic foot ulcers
    • 5.5.2.1. Diabetic foot ulcers market estimates and forecast 2021 to 2033 (USD Million)
  • 5.5.3. Pressure ulcers
    • 5.5.3.1. Pressure ulcers market estimates and forecast 2021 to 2033 (USD Million)
  • 5.5.4. Venous leg ulcers
    • 5.5.4.1. Venous leg ulcers market estimates and forecast 2021 to 2033 (USD Million)
  • 5.5.5. Other chronic wounds
    • 5.5.5.1. Other chronic wounds market estimates and forecast 2021 to 2033 (USD Million)

Chapter 6. Wound Closure Devices Market: End Use Estimates & Trend Analysis

• 6.1. Segment Dashboard
• 6.2. Global Wound Closure Devices Market Movement Analysis
• 6.3. Global Wound Closure Devices Market Size & Trend Analysis, by End Use, 2021 to 2033 (USD Million)
• 6.4. Acute Care Hospital
  • 6.4.1. Acute care hospital market estimates and forecast 2021 to 2033 (USD Million)
• 6.5. Ambulatory Surgery Center (ASC)
  • 6.5.1. Ambulatory surgery center (ASC) market estimates and forecast 2021 to 2033 (USD Million)
• 6.6. Hospital Outpatient Wound Care Clinic
  • 6.6.1. Hospital outpatient wound care clinic market estimates and forecast 2021 to 2033 (USD Million)
• 6.7. Home Healthcare
  • 6.7.1. Home healthcare market estimates and forecast 2021 to 2033 (USD Million)
• 6.8. Skilled Nursing Facility (SNF)
  • 6.8.1. Skilled nursing facility (SNF) market estimates and forecast 2021 to 2033 (USD Million)
• 6.9. Physician Office
  • 6.9.1. Physician office market estimates and forecast 2021 to 2033 (USD Million)
• 6.10. Burn Center
  • 6.10.1. Burn center market estimates and forecast 2021 to 2033 (USD Million)
• 6.11. Inpatient Rehabilitation Facility (IRF)
  • 6.11.1. Inpatient rehabilitation facility (IRF) market estimates and forecast 2021 to 2033 (USD Million)
• 6.12. Long-term Acute Care Hospital (LTACH)
  • 6.12.1. Long-term acute care hospital (LTACH) market estimates and forecast 2021 to 2033 (USD Million)
• 6.13. Long-term care (residential living setting)
  • 6.13.1. Long-term care (residential living setting) market estimates and forecast 2021 to 2033 (USD Million)

Chapter 7. Wound Closure Devices Market: Distribution Channel Estimates & Trend Analysis

• 7.1. Segment Dashboard
• 7.2. Global Wound Closure Devices Market Movement Analysis
• 7.3. Global Wound Closure Devices Market Size & Trend Analysis, by Distribution Channel, 2021 to 2033 (USD Million)
• 7.4. Institutional Sales
  • 7.4.1. Institutional sales market revenue estimates and forecasts, 2021 - 2033 (USD Million)
• 7.5. Retail Sales
  • 7.5.1. Retail sales market revenue estimates and forecasts, 2021 - 2033 (USD Million)

Chapter 8. Wound Closure Devices Market: Mode of Purchase Estimates & Trend Analysis

• 8.1. Segment Dashboard
• 8.2. Global Wound Closure Devices Market Movement Analysis
• 8.3. Global Wound Closure Devices Market Size & Trend Analysis, by Mode of Purchase, 2021 to 2033 (USD Million)
• 8.4. Prescribed
  • 8.4.1. Prescribed market revenue estimates and forecasts, 2021 - 2033 (USD Million)
• 8.5. Non-prescribed (OTC)
  • 8.5.1. Non-prescribed (OTC) market revenue estimates and forecasts, 2021 - 2033 (USD Million)

Chapter 9. Wound Closure Devices Market: Regional Estimates & Trend Analysis By Product, By Wound, By End Use, By Distribution Channel and By Mode of Purchase

• 9.1. Regional Dashboard
• 9.2. Market Size & Forecasts and Trend Analysis, 2021 to 2033
• 9.3. North America
  • 9.3.1. North America Wound Closure Devices Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 9.3.2. U.S.
    • 9.3.2.1. Key Country Dynamics
    • 9.3.2.2. Competitive Scenario
    • 9.3.2.3. Regulatory Scenario
    • 9.3.2.4. Reimbursement Scenario
    • 9.3.2.5. U.S. Wound Closure Devices Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 9.3.3. Canada
    • 9.3.3.1. Key Country Dynamics
    • 9.3.3.2. Competitive Scenario
    • 9.3.3.3. Regulatory Scenario
    • 9.3.3.4. Reimbursement Scenario
    • 9.3.3.5. Canada Wound Closure Devices Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 9.3.4. Mexico
    • 9.3.4.1. Key Country Dynamics
    • 9.3.4.2. Competitive Scenario
    • 9.3.4.3. Regulatory Scenario
    • 9.3.4.4. Reimbursement Scenario
    • 9.3.4.5. Mexico Wound Closure Devices Market Estimates and Forecasts, 2021 - 2033 (USD Million)
• 9.4. Europe
  • 9.4.1. Europe Wound Closure Devices Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 9.4.2. UK
    • 9.4.2.1. Key Country Dynamics
    • 9.4.2.2. Competitive Scenario
    • 9.4.2.3. Regulatory Scenario
    • 9.4.2.4. Reimbursement Scenario
    • 9.4.2.5. UK Wound Closure Devices Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 9.4.3. Germany
    • 9.4.3.1. Key Country Dynamics
    • 9.4.3.2. Competitive Scenario
    • 9.4.3.3. Regulatory Scenario
    • 9.4.3.4. Reimbursement Scenario
    • 9.4.3.5. Germany Wound Closure Devices Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 9.4.4. France
    • 9.4.4.1. Key Country Dynamics
    • 9.4.4.2. Competitive Scenario
    • 9.4.4.3. Regulatory Scenario
    • 9.4.4.4. Reimbursement Scenario
    • 9.4.4.5. France Wound Closure Devices Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 9.4.5. Italy
    • 9.4.5.1. Key Country Dynamics
    • 9.4.5.2. Competitive Scenario
    • 9.4.5.3. Regulatory Scenario
    • 9.4.5.4. Reimbursement Scenario
    • 9.4.5.5. Italy Wound Closure Devices Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 9.4.6. Spain
    • 9.4.6.1. Key Country Dynamics
    • 9.4.6.2. Competitive Scenario
    • 9.4.6.3. Regulatory Scenario
    • 9.4.6.4. Reimbursement Scenario
    • 9.4.6.5. Spain Wound Closure Devices Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 9.4.7. Denmark
    • 9.4.7.1. Key Country Dynamics
    • 9.4.7.2. Competitive Scenario
    • 9.4.7.3. Regulatory Scenario
    • 9.4.7.4. Reimbursement Scenario
    • 9.4.7.5. Denmark Wound Closure Devices Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 9.4.8. Sweden
    • 9.4.8.1. Key Country Dynamics
    • 9.4.8.2. Competitive Scenario
    • 9.4.8.3. Regulatory Scenario
    • 9.4.8.4. Reimbursement Scenario
    • 9.4.8.5. Sweden Wound Closure Devices Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 9.4.9. Norway
    • 9.4.9.1. Key Country Dynamics
    • 9.4.9.2. Competitive Scenario
    • 9.4.9.3. Regulatory Scenario
    • 9.4.9.4. Reimbursement Scenario
    • 9.4.9.5. Norway Wound Closure Devices Market Estimates and Forecasts, 2021 - 2033 (USD Million)
• 9.5. Asia Pacific
  • 9.5.1. Asia Pacific Wound Closure Devices Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 9.5.2. Japan
    • 9.5.2.1. Key Country Dynamics
    • 9.5.2.2. Competitive Scenario
    • 9.5.2.3. Regulatory Scenario
    • 9.5.2.4. Reimbursement Scenario
    • 9.5.2.5. Japan Wound Closure Devices Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 9.5.3. China
    • 9.5.3.1. Key Country Dynamics
    • 9.5.3.2. Competitive Scenario
    • 9.5.3.3. Regulatory Scenario
    • 9.5.3.4. Reimbursement Scenario
    • 9.5.3.5. China Wound Closure Devices Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 9.5.4. India
    • 9.5.4.1. Key Country Dynamics
    • 9.5.4.2. Competitive Scenario
    • 9.5.4.3. Regulatory Scenario
    • 9.5.4.4. Reimbursement Scenario
    • 9.5.4.5. India Wound Closure Devices Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 9.5.5. South Korea
    • 9.5.5.1. Key Country Dynamics
    • 9.5.5.2. Competitive Scenario
    • 9.5.5.3. Regulatory Scenario
    • 9.5.5.4. Reimbursement Scenario
    • 9.5.5.5. South Korea Wound Closure Devices Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 9.5.6. Australia
    • 9.5.6.1. Key Country Dynamics
    • 9.5.6.2. Competitive Scenario
    • 9.5.6.3. Regulatory Scenario
    • 9.5.6.4. Reimbursement Scenario
    • 9.5.6.5. Australia Wound Closure Devices Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 9.5.7. Thailand
    • 9.5.7.1. Key Country Dynamics
    • 9.5.7.2. Competitive Scenario
    • 9.5.7.3. Regulatory Scenario
    • 9.5.7.4. Reimbursement Scenario
    • 9.5.7.5. Thailand Wound Closure Devices Market Estimates and Forecasts, 2021 - 2033 (USD Million)
• 9.6. Latin America
  • 9.6.1. Latin America Wound Closure Devices Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 9.6.2. Brazil
    • 9.6.2.1. Key Country Dynamics
    • 9.6.2.2. Competitive Scenario
    • 9.6.2.3. Regulatory Scenario
    • 9.6.2.4. Reimbursement Scenario
    • 9.6.2.5. Brazil Wound Closure Devices Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 9.6.3. Argentina
    • 9.6.3.1. Key Country Dynamics
    • 9.6.3.2. Competitive Scenario
    • 9.6.3.3. Regulatory Scenario
    • 9.6.3.4. Reimbursement Scenario
    • 9.6.3.5. Argentina Wound Closure Devices Market Estimates and Forecasts, 2021 - 2033 (USD Million)
• 9.7. Middle East & Africa
  • 9.7.1. Middle East & Africa Wound Closure Devices Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 9.7.2. South Africa
    • 9.7.2.1. Key Country Dynamics
    • 9.7.2.2. Competitive Scenario
    • 9.7.2.3. Regulatory Scenario
    • 9.7.2.4. Reimbursement Scenario
    • 9.7.2.5. South Africa Wound Closure Devices Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 9.7.3. Saudi Arabia
    • 9.7.3.1. Key Country Dynamics
    • 9.7.3.2. Competitive Scenario
    • 9.7.3.3. Regulatory Scenario
    • 9.7.3.4. Reimbursement Scenario
    • 9.7.3.5. Saudi Arabia Wound Closure Devices Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 9.7.4. UAE
    • 9.7.4.1. Key Country Dynamics
    • 9.7.4.2. Competitive Scenario
    • 9.7.4.3. Regulatory Scenario
    • 9.7.4.4. Reimbursement Scenario
    • 9.7.4.5. UAE Wound Closure Devices Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 9.7.5. Kuwait
    • 9.7.5.1. Key Country Dynamics
    • 9.7.5.2. Competitive Scenario
    • 9.7.5.3. Regulatory Scenario
    • 9.7.5.4. Reimbursement Scenario
    • 9.7.5.5. Kuwait Wound Closure Devices Market Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 10. Competitive Landscape

• 10.1. Market Participant Categorization
• 10.2. Key Company Profiles
  • 10.2.1. Solventum
    • 10.2.1.1. Company Overview
    • 10.2.1.2. Financial Performance
    • 10.2.1.3. Product Benchmarking
    • 10.2.1.4. Strategic Initiatives
  • 10.2.2. 3M
    • 10.2.2.1. Company Overview
    • 10.2.2.2. Financial Performance
    • 10.2.2.3. Product Benchmarking
    • 10.2.2.4. Strategic Initiatives
  • 10.2.3. DeRoyal Industries, Inc.
    • 10.2.3.1. Company Overview
    • 10.2.3.2. Financial Performance
    • 10.2.3.3. Product Benchmarking
    • 10.2.3.4. Strategic Initiatives
  • 10.2.4. DermaRite Industries, LLC.
    • 10.2.4.1. Company Overview
    • 10.2.4.2. Financial Performance
    • 10.2.4.3. Product Benchmarking
    • 10.2.4.4. Strategic Initiatives
  • 10.2.5. B. Braun SE
    • 10.2.5.1. Company Overview
    • 10.2.5.2. Financial Performance
    • 10.2.5.3. Product Benchmarking
    • 10.2.5.4. Strategic Initiatives
  • 10.2.6. Cardinal Health
    • 10.2.6.1. Company Overview
    • 10.2.6.2. Financial Performance
    • 10.2.6.3. Product Benchmarking
    • 10.2.6.4. Strategic Initiatives
  • 10.2.7. Baxter
    • 10.2.7.1. Company Overview
    • 10.2.7.2. Financial Performance
    • 10.2.7.3. Product Benchmarking
    • 10.2.7.4. Strategic Initiatives
  • 10.2.8. Stryker
    • 10.2.8.1. Company Overview
    • 10.2.8.2. Financial Performance
    • 10.2.8.3. Product Benchmarking
    • 10.2.8.4. Strategic Initiatives
  • 10.2.9. Smith+Nephew
    • 10.2.9.1. Company Overview
    • 10.2.9.2. Financial Performance
    • 10.2.9.3. Product Benchmarking
    • 10.2.9.4. Strategic Initiatives
  • 10.2.10. Medtronic
    • 10.2.10.1. Company Overview
    • 10.2.10.2. Financial Performance
    • 10.2.10.3. Product Benchmarking
    • 10.2.10.4. Strategic Initiatives
  • 10.2.11. Ethicon (Johnson & Johnson)
    • 10.2.11.1. Company Overview
    • 10.2.11.2. Financial Performance
    • 10.2.11.3. Product Benchmarking
    • 10.2.11.4. Strategic Initiatives
  • 10.2.12. Riverpoint Medical
    • 10.2.12.1. Company Overview
    • 10.2.12.2. Financial Performance
    • 10.2.12.3. Product Benchmarking
    • 10.2.12.4. Strategic Initiatives
  • 10.2.13. DermaClip
    • 10.2.13.1. Company Overview
    • 10.2.13.2. Financial Performance
    • 10.2.13.3. Product Benchmarking
    • 10.2.13.4. Strategic Initiatives
  • 10.2.14. Medline Industries, LP
    • 10.2.14.1. Company Overview
    • 10.2.14.2. Financial Performance
    • 10.2.14.3. Product Benchmarking
    • 10.2.14.4. Strategic Initiatives
  • 10.2.15. Gentell
    • 10.2.15.1. v Company Overview
    • 10.2.15.2. Financial Performance
    • 10.2.15.3. Product Benchmarking
    • 10.2.15.4. Strategic Initiatives
  • 10.2.16. Dynarex Corporation
    • 10.2.16.1. Company Overview
    • 10.2.16.2. Financial Performance
    • 10.2.16.3. Product Benchmarking
    • 10.2.16.4. Strategic Initiatives
  • 10.2.17. Corza Medical
    • 10.2.17.1. Company Overview
    • 10.2.17.2. Financial Performance
    • 10.2.17.3. Product Benchmarking
    • 10.2.17.4. Strategic Initiatives
  • 10.2.18. Dukal, LLC
    • 10.2.18.1. Company Overview
    • 10.2.18.2. Financial Performance
    • 10.2.18.3. Product Benchmarking
    • 10.2.18.4. Strategic Initiatives
  • 10.2.19. Aspen Surgical Products, Inc.
    • 10.2.19.1. Company Overview
    • 10.2.19.2. Financial Performance
    • 10.2.19.3. Product Benchmarking
    • 10.2.19.4. Strategic Initiatives
  • 10.2.20. Essity Health & Medical (Essity)
    • 10.2.20.1. Company Overview
    • 10.2.20.2. Financial Performance
    • 10.2.20.3. Product Benchmarking
    • 10.2.20.4. Strategic Initiatives
  • 10.2.21. Aero Healthcare
    • 10.2.21.1. Company Overview
    • 10.2.21.2. Financial Performance
    • 10.2.21.3. Product Benchmarking
    • 10.2.21.4. Strategic Initiatives
  • 10.2.22. Healthium Medtech Ltd.
    • 10.2.22.1. Company Overview
    • 10.2.22.2. Financial Performance
    • 10.2.22.3. Product Benchmarking
    • 10.2.22.4. Strategic Initiatives
  • 10.2.23. KitoTech Medical, Inc.
    • 10.2.23.1. Company Overview
    • 10.2.23.2. Financial Performance
    • 10.2.23.3. Product Benchmarking
    • 10.2.23.4. Strategic Initiatives
  • 10.2.24. Trusetal Verbandstoffwerk GmbH
    • 10.2.24.1. Company Overview
    • 10.2.24.2. Financial Performance
    • 10.2.24.3. Product Benchmarking
    • 10.2.24.4. Strategic Initiatives
  • 10.2.25. Advanced Medical Solutions Group plc
    • 10.2.25.1. Company Overview
    • 10.2.25.2. Financial Performance
    • 10.2.25.3. Product Benchmarking
    • 10.2.25.4. Strategic Initiatives
  • 10.2.26. H.B. Fuller Medical Adhesive Technologies, LLC
    • 10.2.26.1. Company Overview
    • 10.2.26.2. Financial Performance
    • 10.2.26.3. Product Benchmarking
    • 10.2.26.4. Strategic Initiatives
  • 10.2.27. AVITA Medical, Inc.
    • 10.2.27.1. Company Overview
    • 10.2.27.2. Financial Performance
    • 10.2.27.3. Product Benchmarking
    • 10.2.27.4. Strategic Initiatives
  • 10.2.28. Meril
    • 10.2.28.1. Company Overview
    • 10.2.28.2. Financial Performance
    • 10.2.28.3. Product Benchmarking
    • 10.2.28.4. Strategic Initiatives
  • 10.2.29. Terumo Corporation
    • 10.2.29.1. Company Overview
    • 10.2.29.2. Financial Performance
    • 10.2.29.3. Product Benchmarking
    • 10.2.29.4. Strategic Initiatives
  • 10.2.30. CliniSut
    • 10.2.30.1. Company Overview
    • 10.2.30.2. Financial Performance
    • 10.2.30.3. Product Benchmarking
    • 10.2.30.4. Strategic Initiatives
  • 10.2.31. Synthecon
    • 10.2.31.1. Company Overview
    • 10.2.31.2. Financial Performance
    • 10.2.31.3. Product Benchmarking
    • 10.2.31.4. Strategic Initiatives
  • 10.2.32. Dolphin Sutures (Futura Surgicare Pvt Ltd)
    • 10.2.32.1. Company Overview
    • 10.2.32.2. Financial Performance
    • 10.2.32.3. Product Benchmarking
    • 10.2.32.4. Strategic Initiatives
  • 10.2.33. Unisur Lifecare
    • 10.2.33.1. Company Overview
    • 10.2.33.2. Financial Performance
    • 10.2.33.3. Product Benchmarking
    • 10.2.33.4. Strategic Initiatives
  • 10.2.34. AdvaCare Pharma
    • 10.2.34.1. Company Overview
    • 10.2.34.2. Financial Performance
    • 10.2.34.3. Product Benchmarking
    • 10.2.34.4. Strategic Initiatives
  • 10.2.35. Suzhou Sunmed Co., Ltd.
    • 10.2.35.1. Company Overview
    • 10.2.35.2. Financial Performance
    • 10.2.35.3. Product Benchmarking
    • 10.2.35.4. Strategic Initiatives
  • 10.2.36. Samyang Biopharm Corporation
    • 10.2.36.1. Company Overview
    • 10.2.36.2. Financial Performance
    • 10.2.36.3. Product Benchmarking
    • 10.2.36.4. Strategic Initiatives
  • 10.2.37. Baihe Medical
    • 10.2.37.1. Company Overview
    • 10.2.37.2. Financial Performance
    • 10.2.37.3. Product Benchmarking
    • 10.2.37.4. Strategic Initiatives
  • 10.2.38. MUB Medical.
    • 10.2.38.1. Company Overview
    • 10.2.38.2. Financial Performance
    • 10.2.38.3. Product Benchmarking
    • 10.2.38.4. Strategic Initiatives
  • 10.2.39. BRIJ Medical
    • 10.2.39.1. Company Overview
    • 10.2.39.2. Financial Performance
    • 10.2.39.3. Product Benchmarking
    • 10.2.39.4. Strategic Initiatives
  • 10.2.40. Southmedic Inc.
    • 10.2.40.1. Company Overview
    • 10.2.40.2. Financial Performance
    • 10.2.40.3. Product Benchmarking
    • 10.2.40.4. Strategic Initiatives
  • 10.2.41. Sylke, Inc.
    • 10.2.41.1. Company Overview
    • 10.2.41.2. Financial Performance
    • 10.2.41.3. Product Benchmarking
    • 10.2.41.4. Strategic Initiatives
  • 10.2.42. Clozex Medical, Inc.
    • 10.2.42.1. Company Overview
    • 10.2.42.2. Financial Performance
    • 10.2.42.3. Product Benchmarking
    • 10.2.42.4. Strategic Initiatives
  • 10.2.43. DemeTECH
    • 10.2.43.1. Company Overview
    • 10.2.43.2. Financial Performance
    • 10.2.43.3. Product Benchmarking
    • 10.2.43.4. Strategic Initiatives
  • 10.2.44. Teleflex (incl. Weck)
    • 10.2.44.1. Company Overview
    • 10.2.44.2. Financial Performance
    • 10.2.44.3. Product Benchmarking
    • 10.2.44.4. Strategic Initiatives
  • 10.2.45. Lotus Surgicals
    • 10.2.45.1. Company Overview
    • 10.2.45.2. Financial Performance
    • 10.2.45.3. Product Benchmarking
    • 10.2.45.4. Strategic Initiatives
  • 10.2.46. Internacional Farmaceutica
    • 10.2.46.1. Company Overview
    • 10.2.46.2. Financial Performance
    • 10.2.46.3. Product Benchmarking
    • 10.2.46.4. Strategic Initiatives
  • 10.2.47. Serag-Wiessner
    • 10.2.47.1. Company Overview
    • 10.2.47.2. Financial Performance
    • 10.2.47.3. Product Benchmarking
    • 10.2.47.4. Strategic Initiatives
  • 10.2.48. Lux Sutures
    • 10.2.48.1. Company Overview
    • 10.2.48.2. Financial Performance
    • 10.2.48.3. Product Benchmarking
    • 10.2.48.4. Strategic Initiatives
  • 10.2.49. Chemence Medical
    • 10.2.49.1. Company Overview
    • 10.2.49.2. Financial Performance
    • 10.2.49.3. Product Benchmarking
    • 10.2.49.4. Strategic Initiatives
  • 10.2.50. Intuitive Surgical
    • 10.2.50.1. Company Overview
    • 10.2.50.2. Financial Performance
    • 10.2.50.3. Product Benchmarking
    • 10.2.50.4. Strategic Initiatives
  • 10.2.51. Frankenman
    • 10.2.51.1. Company Overview
    • 10.2.51.2. Financial Performance
    • 10.2.51.3. Product Benchmarking
    • 10.2.51.4. Strategic Initiatives
  • 10.2.52. Reach Surgical (Genesis MedTech)
    • 10.2.52.1. Company Overview
    • 10.2.52.2. Financial Performance
    • 10.2.52.3. Product Benchmarking
    • 10.2.52.4. Strategic Initiatives
  • 10.2.53. Purple Surgical
    • 10.2.53.1. Company Overview
    • 10.2.53.2. Financial Performance
    • 10.2.53.3. Product Benchmarking
    • 10.2.53.4. Strategic Initiatives
  • 10.2.54. Grena Ltd
    • 10.2.54.1. Company Overview
    • 10.2.54.2. Financial Performance
    • 10.2.54.3. Product Benchmarking
    • 10.2.54.4. Strategic Initiatives
  • 10.2.55. Ackermann Surgical
    • 10.2.55.1. Company Overview
    • 10.2.55.2. Financial Performance
    • 10.2.55.3. Product Benchmarking
    • 10.2.55.4. Strategic Initiatives
  • 10.2.56. CSL Behring
    • 10.2.56.1. Company Overview
    • 10.2.56.2. Financial Performance
    • 10.2.56.3. Product Benchmarking
    • 10.2.56.4. Strategic Initiatives
  • 10.2.57. Integra LifeSciences
    • 10.2.57.1. Company Overview
    • 10.2.57.2. Financial Performance
    • 10.2.57.3. Product Benchmarking
    • 10.2.57.4. Strategic Initiatives
  • 10.2.58. Artivion (formerly CryoLife)
    • 10.2.58.1. Company Overview
    • 10.2.58.2. Financial Performance
    • 10.2.58.3. Product Benchmarking
    • 10.2.58.4. Strategic Initiatives
  • 10.2.59. Takeda
    • 10.2.59.1. Company Overview
    • 10.2.59.2. Financial Performance
    • 10.2.59.3. Product Benchmarking
    • 10.2.59.4. Strategic Initiatives
  • 10.2.60. McKesson Medical-Surgical
    • 10.2.60.1. Company Overview
    • 10.2.60.2. Financial Performance
    • 10.2.60.3. Product Benchmarking
    • 10.2.60.4. Strategic Initiatives
  • 10.2.61. Molnlycke Health Care
    • 10.2.61.1. Company Overview
    • 10.2.61.2. Financial Performance
    • 10.2.61.3. Product Benchmarking
    • 10.2.61.4. Strategic Initiatives
  • 10.2.62. Paul Hartmann AG
    • 10.2.62.1. Company Overview
    • 10.2.62.2. Financial Performance
    • 10.2.62.3. Product Benchmarking
    • 10.2.62.4. Strategic Initiatives
  • 10.2.63. Lohmann & Rauscher
    • 10.2.63.1. Company Overview
    • 10.2.63.2. Financial Performance
    • 10.2.63.3. Product Benchmarking
    • 10.2.63.4. Strategic Initiatives
• 10.3. Heat Map Analysis/ Company Market Position Analysis
• 10.4. Estimated Company Market Share Analysis, 2025
• 10.5. List of Other Key Market Players